WO2002086513A3 - Transcobalamin ii assay method - Google Patents

Transcobalamin ii assay method Download PDF

Info

Publication number
WO2002086513A3
WO2002086513A3 PCT/GB2002/001846 GB0201846W WO02086513A3 WO 2002086513 A3 WO2002086513 A3 WO 2002086513A3 GB 0201846 W GB0201846 W GB 0201846W WO 02086513 A3 WO02086513 A3 WO 02086513A3
Authority
WO
WIPO (PCT)
Prior art keywords
transcobalamin
ligand
binding partner
binding
assay method
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/GB2002/001846
Other languages
French (fr)
Other versions
WO2002086513A2 (en
Inventor
Lars Oerning
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Axis Shield ASA
Original Assignee
Axis Shield ASA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to EP02724424A priority Critical patent/EP1384083B1/en
Priority to AT02724424T priority patent/ATE285582T1/en
Priority to DE2002602361 priority patent/DE60202361T2/en
Priority to DK02724424T priority patent/DK1384083T3/en
Priority to CA 2445089 priority patent/CA2445089A1/en
Priority to JP2002583990A priority patent/JP3935437B2/en
Priority to AU2002255117A priority patent/AU2002255117B2/en
Priority to US10/474,506 priority patent/US7501287B2/en
Application filed by Axis Shield ASA filed Critical Axis Shield ASA
Publication of WO2002086513A2 publication Critical patent/WO2002086513A2/en
Publication of WO2002086513A3 publication Critical patent/WO2002086513A3/en
Priority to NO20034707A priority patent/NO331783B1/en
Anticipated expiration legal-status Critical
Priority to US12/289,291 priority patent/US9140710B2/en
Ceased legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/82—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving vitamins or their receptors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/44—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • G01N33/5735—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes co-enzymes or co-factors, e.g. NAD or ATP
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/32—Immunoglobulins specific features characterized by aspects of specificity or valency specific for a neo-epitope on a complex, e.g. antibody-antigen or ligand-receptor

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Semiconductor Lasers (AREA)

Abstract

An assay method for determining transcobalamin saturation wherein a transcobalamin containing liquid sample is contacted with a porous substrate with immobilized thereon a transcobalamin immobilizing ligand and with a reporter-labelled transcobalamin binding partner and wherein signals from reporter labels which become immobilized on said substrate are detected, characterised in that one of said ligand or said binding partner comprises a first ligand or binding partner capable of specific binding to holo transcobalamin and a second ligand or binding partner capable of binding to apo transcobalamin or to holo and apo transcobalamin.
PCT/GB2002/001846 2001-04-23 2002-04-23 Transcobalamin ii assay method Ceased WO2002086513A2 (en)

Priority Applications (10)

Application Number Priority Date Filing Date Title
AU2002255117A AU2002255117B2 (en) 2001-04-23 2002-04-23 Transcobalamin II assay method
DE2002602361 DE60202361T2 (en) 2001-04-23 2002-04-23 PROCESS FOR DETERMINING TRANSCOBALAMINE II
DK02724424T DK1384083T3 (en) 2001-04-23 2002-04-23 Method for Detecting Transcobalamin II
CA 2445089 CA2445089A1 (en) 2001-04-23 2002-04-23 Transcobalamin ii assay method
JP2002583990A JP3935437B2 (en) 2001-04-23 2002-04-23 Transcobalamin II analysis method
EP02724424A EP1384083B1 (en) 2001-04-23 2002-04-23 Transcobalamin ii assay method
AT02724424T ATE285582T1 (en) 2001-04-23 2002-04-23 METHOD FOR DETERMINING TRANSCOBALAMINE II
US10/474,506 US7501287B2 (en) 2001-04-23 2002-04-23 Transcobalamin II assay method
NO20034707A NO331783B1 (en) 2001-04-23 2003-10-21 Transcobalamin saturation test method as well as kits for performing such testing
US12/289,291 US9140710B2 (en) 2001-04-23 2008-10-24 Transcobalamin II assay method

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0109925.8 2001-04-23
GB0109925A GB0109925D0 (en) 2001-04-23 2001-04-23 Method

Related Child Applications (2)

Application Number Title Priority Date Filing Date
US10474506 A-371-Of-International 2001-04-23
US12/289,291 Division US9140710B2 (en) 2001-04-23 2008-10-24 Transcobalamin II assay method

Publications (2)

Publication Number Publication Date
WO2002086513A2 WO2002086513A2 (en) 2002-10-31
WO2002086513A3 true WO2002086513A3 (en) 2003-04-10

Family

ID=9913282

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB2002/001846 Ceased WO2002086513A2 (en) 2001-04-23 2002-04-23 Transcobalamin ii assay method

Country Status (13)

Country Link
US (2) US7501287B2 (en)
EP (1) EP1384083B1 (en)
JP (1) JP3935437B2 (en)
AT (1) ATE285582T1 (en)
AU (1) AU2002255117B2 (en)
CA (1) CA2445089A1 (en)
DE (1) DE60202361T2 (en)
ES (1) ES2235034T3 (en)
GB (1) GB0109925D0 (en)
NO (1) NO331783B1 (en)
PT (1) PT1384083E (en)
TR (1) TR200402398T3 (en)
WO (1) WO2002086513A2 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1565490T3 (en) * 2002-11-26 2010-08-23 Axis Shield Asa Holo-transcobalamin binding partners and their use in cobalamin testing
GB0305904D0 (en) * 2003-03-14 2003-04-23 Cobento Biotech Aps Test
JP4949397B2 (en) * 2006-06-26 2012-06-06 日本電信電話株式会社 Sensor element for SPR measurement
WO2008106648A2 (en) * 2007-03-01 2008-09-04 Abbott Laboratories Immunoassays exhibiting a reduction in prozone phenomena
US8835120B2 (en) * 2009-12-02 2014-09-16 Abbott Laboratories Assay for cardiac troponin-T (cTnT)
WO2013149266A1 (en) * 2012-03-31 2013-10-03 Nvigen, Inc. Multifunctional nanoparticles for molecular and cellular separation, detection and quantification
US9157910B2 (en) * 2013-03-15 2015-10-13 Abbott Laboratories Assay with increased dynamic range
CN114206367B (en) * 2019-08-09 2024-07-19 美国西门子医学诊断股份有限公司 Anti-porcine TCN1 monoclonal antibodies and methods of producing and using the same

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4273757A (en) * 1977-06-02 1981-06-16 Yissum Research Development Company Determination of transcobalamins
WO2000017659A1 (en) * 1998-09-18 2000-03-30 Axis-Shield Asa Cobalamin assay

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4595661A (en) * 1983-11-18 1986-06-17 Beckman Instruments, Inc. Immunoassays and kits for use therein which include low affinity antibodies for reducing the hook effect
US4632901A (en) * 1984-05-11 1986-12-30 Hybritech Incorporated Method and apparatus for immunoassays
GB8501671D0 (en) * 1985-01-23 1985-02-27 Allen G J Immunoassay
JPH01163661A (en) * 1987-10-02 1989-06-27 E I Du Pont De Nemours & Co Immunoassay using IgG capture antibody and multiple monoclonal antibody detection system
US5279937A (en) * 1992-04-30 1994-01-18 Detechnology Canada Use of macroglobulins to improve the signal-to-background ratio in affinity binding assays
JPH07508174A (en) * 1992-05-08 1995-09-14 レセプタジェン　コーポレイション Anti-receptor agent for vitamin B12/transcobalamin 2 receptor
US5485277A (en) * 1994-07-26 1996-01-16 Physical Optics Corporation Surface plasmon resonance sensor and methods for the utilization thereof
ATE281648T1 (en) * 1995-04-18 2004-11-15 Biosite Diagnostics Inc METHOD FOR ASSAYING TROPONIN I AND T AND TROPONIN I AND T COMPLEXES AND SELECTION OF ANTIBODIES FOR USE IN IMMUNOASSAYS
DE19629657A1 (en) * 1996-07-23 1998-01-29 Boehringer Mannheim Gmbh Volume-independent diagnostic test carrier and method for determining analyte with its aid
JP3334558B2 (en) * 1997-04-23 2002-10-15 富士レビオ株式会社 Enzyme immunoassay and test strips
KR100348351B1 (en) * 2000-05-24 2002-08-09 주식회사 바이오디지트 Electrochemical membrane strip biosensor

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4273757A (en) * 1977-06-02 1981-06-16 Yissum Research Development Company Determination of transcobalamins
WO2000017659A1 (en) * 1998-09-18 2000-03-30 Axis-Shield Asa Cobalamin assay

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
NEXO EBBA ET AL: "Measurement of transcobalamin by ELISA.", CLINICAL CHEMISTRY, vol. 46, no. 10, October 2000 (2000-10-01), pages 1643 - 1649, XP001145456, ISSN: 0009-9147 *
ULLELAND MARIUS ET AL: "Direct assay for cobalamin bound to transcobalamin (holo-transcobalamin) in serum.", CLINICAL CHEMISTRY, vol. 48, no. 3, March 2002 (2002-03-01), pages 526 - 532, XP001145417, ISSN: 0009-9147 *
WICKRAMASINGHE S N ET AL: "LIMITED VALUE OF SERUM HOLO-TRANSCOBALAMIN II MEASUREMENTS IN THE DIFFERENTIAL DIAGNOSIS OF MACROCYTOSIS", JOURNAL OF CLINICAL PATHOLOGY, LONDON, GB, vol. 49, no. 9, September 1996 (1996-09-01), pages 755 - 758, XP001058213, ISSN: 0021-9746 *

Also Published As

Publication number Publication date
NO20034707D0 (en) 2003-10-21
AU2002255117B2 (en) 2008-04-03
NO20034707L (en) 2003-12-17
DE60202361T2 (en) 2005-12-22
US20100099129A1 (en) 2010-04-22
JP3935437B2 (en) 2007-06-20
GB0109925D0 (en) 2001-06-13
WO2002086513A2 (en) 2002-10-31
EP1384083B1 (en) 2004-12-22
ATE285582T1 (en) 2005-01-15
DE60202361D1 (en) 2005-01-27
ES2235034T3 (en) 2005-07-01
TR200402398T3 (en) 2004-11-22
JP2004526973A (en) 2004-09-02
NO331783B1 (en) 2012-03-26
US9140710B2 (en) 2015-09-22
EP1384083A2 (en) 2004-01-28
US7501287B2 (en) 2009-03-10
CA2445089A1 (en) 2002-10-31
US20040132213A1 (en) 2004-07-08
PT1384083E (en) 2005-04-29

Similar Documents

Publication Publication Date Title
AU1359588A (en) Solid phase assay
EP0895084A3 (en) Device and method for obtaining clinically significant analyte ratios
WO2002018949A3 (en) Capillary array and related methods
AU2002322241A1 (en) Rapid diagnostic device, assay and multifunctional buffer
WO1999022017A3 (en) Device and methods for determination of analyte in a solution
WO2004041061A8 (en) Substrates, devices, and methods for cellular assays
CA2254108A1 (en) Improvements in or relating to specific binding assays
AU2706384A (en) Colorimetric immunoassay on solid surface
EP0657737A3 (en) Method and reagents for binding chemical analytes to a substrate surface, and related analytical devices and diagnostic techniques.
AU6834700A (en) Device and method for determining multiple analytes
WO2005089082A3 (en) Assay device and method
EP0984281A3 (en) A homogeneous assay for determining analyte
WO2005029073A8 (en) Chromatographic assay device and methods
WO2003040670A3 (en) Method of identifying energy transfer sensors for analytes
WO2003023051A3 (en) Lateral flow test format for enzyme assays
EP1845375A3 (en) Flow through assay device, diagnostic kit comprising said device and use in the detection of an analyte in a sample
GB0109925D0 (en) Method
EP0113075A3 (en) Field immunoassay reaction system, method of immunoassay diagnosis and probe or carrier for use therewith
AU6414698A (en) Recording assay device
CA2344193A1 (en) Cobalamin assay
WO2006003394A8 (en) Analyte detection system
EP1069433A3 (en) Agglutination assay method in porous medium layer
DE59907982D1 (en) Method for the detection of a protease activated in apoptosis
WO2006071970A3 (en) Methods for the detection of analytes in a sample
WO2001096597A3 (en) High throughput screening of compounds for biological activity

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 2002255117

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 2002583990

Country of ref document: JP

WWE Wipo information: entry into national phase

Ref document number: 2445089

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2002724424

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2002724424

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 10474506

Country of ref document: US

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWG Wipo information: grant in national office

Ref document number: 2002724424

Country of ref document: EP